Consistently, p53 perturbation by pharmacologic inhibitor pifithrin-α (PFT-α), RNAi or genetic deletion significantly rescue the neurodegeneration in HD models (Bae et al., 2005). This evidence concerns the gene TP53 and Huntington disease.